The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Bridged Bicyclo Compounds, Heterocyclic

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Bridged Bicyclo Compounds, Heterocyclic.
Olatoyosi Odenike
Connection Strength
0.048
Bridged Bicyclo Compounds, Heterocyclic
  1. A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia. Cancer. 2021 08 15; 127(16):2943-2953.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.